Latest Content

Latest Content

Your goal is to improve patients’ lives. Our goal is to make that easier for you.

Decentralized trial tools and technologies are here to stay: A regulatory perspective

COVID-19 led to an era of remarkable regulatory flexibility and innovation with Decentralized Clinical Trial (DCT) strategies and tools but are they here to stay? Read more in this article.

Read More
Loading, please wait

Error - something went wrong!

Let's start a conversation...

Thank you! We'll be in touch soon.
Maximize the efficiency of regulatory operations with five key competencies

Read More
Lessons from China and the United States on the use of RWE in regulatory submissions

Read More
Four reasons to conduct robust natural history studies before clinical trials

Lucas Kempf, former regulator, reflects on his time at the FDA and outlines why companies should invest in a high-quality natural history study.

Learn More
Can Synthetic / External Control Arms meet regulatory and HTA requirements?

This article summarizes a recent panel discussion where experts from Parexel and biotech company, MorphoSys, shared their experiences from recent pioneering efforts in RWE.

Read More
Get the eBook
4 insights on decentralized trials for biotechs _ BioPharma Dive.PXRL

Read More
How to accelerate oncology clinical trials through site relationships and patient insights

Learn how all stakeholders benefit when patients and their insights are at the heart of every aspect of clinical development.

Read More
Four Keys to a Smoother Clinical Development Journey

Whitepaper recently published in Fierce Biotech providing perspectives on how the right partner can help bring all the disciplines together for a successful development program.

Read More
Multi-stakeholder strategies for external control arms

New ways of thinking are needed about vast sources of data amassed — and how that data can be fit-for-purpose to meet drug approval and access standards.

Read More
How a joined-up development strategy pays off for early-stage biotechs

Parexel Biotech’s Nate Akers, VP, Business Development, and Vicky Hsu, Head of Operations in Asia discuss the importance of aligning clinical execution with a clearly defined regulatory strategy.

Read More
Decentralized Trials: Considerations for Building a New Patient-Centric Model

Graciela Racaro, Global Head of Operations for Parexel Biotech, discusses the advances we have seen in the past year towards a more patient-centric environment.

Learn More
Our latest Cell & Gene Therapy content, all in one place
See more
Jim Anthony: A personal connection to driving great medicine in the future

Jim Anthony, Global Head of Parexel Biotech, describes how losing his father to an incurable disease and his early experiences in science and business led him to his role helping biotech companies.

Watch Video
Get the eBook
Graciela Racaro: A personal connection to driving great medicine in the future

Graciela Rácaro, Global Head of Operations for Parexel Biotech, discusses how she has had to change the course of her career direction multiple times on the way to meeting her ultimate goal.

Watch Video
Ubavka DeNoble: Helping our customers in moments that matter

Ubavka DeNoble, Senior Medical Officer for Parexel Biotech, shares how her experiences taught her the power of adapting and persevering against long odds that’s shared by everyone at Parexel Biotech.

Watch Video
Skip Sands: Helping our customers in moments that matter

Skip Sands, Senior Medical Officer for Parexel Biotech, explains how his family history, his career in medicine, and his experience with inadequate medical care inspire him.

Watch Video
Parexel Biotech Brochure

Learn about the services and approaches that Parexel Biotech offers to help you make an exponential difference in patients’ lives.

Read More
Tips for building your oncology reimbursement strategy

In this infographic, we share five tips for building an effective reimbursement strategy for your oncology product.

Learn More
Decentralized clinical trials - A more patient-centric approach

Decentralized clinical trials, where portions of a study are conducted outside a traditional trial site, offer new opportunities — and new hope — for patients struggling with inflammatory conditions.

Read More
Guide for Real-World Evidence

Parexel Biotech has created this guide to simplify the nomenclature and types of real-world studies.

Read More
Entering a new age of evidence generation: synthetic control models

Expert perspectives from Parexel's Leanne Larson, Senior Vice President and WW Head of Real-World Evidence

Read More
Loading More...